People tend to perceive themselves as less swayed than others by COVID-19 misinformation, and the gap helps explain why some people are more open than others to governmental interventions.

Somewhat suddenly, Boston University’s school of medicine has in hand 12,024 applications from students hoping to become MDs. It only has 110 seats. Across the country, Stanford has 11,000 applicants for 90 openings.

The COVID crisis has pushed healthcare providers to up their game on digital health, but the sector is not moving fast enough on this front for the liking of healthcare consumers.

As is so often the case with COVID-19, the numbers sketch out a dauntingly vast landscape while the anecdotes paint portraits of affected human denizens.

Some 501 accountable care organizations and other provider entities are urging Congressional leadership of both parties to modify the “unrealistic threshold tests” set out in the 2021 edition of the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.

Hospitals that have failed to impress patients with COVID safety and quality measures should not be surprised when 2 of 3 patients switch provider orgs—or when 1 in 4 postpone a scheduled procedure indefinitely.

Drawing on nothing more than Facebook activity, psychiatric AI can distinguish individuals headed for hospitalization with schizophrenia from those with worsening mood disorders such as clinical depression and bipolar states. 

There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.

The new guidance is expected to increase the availability of breast imaging services during the pandemic, the administration said recently.

Standard & Poor’s Global Ratings revealed the news in an update shared Dec. 3.